» Articles » PMID: 35269942

Role of Nuclear Receptors in Controlling Erythropoiesis

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Mar 10
PMID 35269942
Authors
Affiliations
Soon will be listed here.
Abstract

Nuclear receptors (NRs), are a wide family of ligand-regulated transcription factors sharing a common modular structure composed by an N-terminal domain and a ligand-binding domain connected by a short hinge linker to a DNA-binding domain. NRs are involved in many physiological processes, including metabolism, reproduction and development. Most of them respond to small lipophilic ligands, such as steroids, retinoids, and phospholipids, which act as conformational switches. Some NRs are still "orphan" and the search for their ligands is still ongoing. Upon DNA binding, NRs can act both as transcriptional activators or repressors of their target genes. Theoretically, the possibility to modulate NRs activity with small molecules makes them ideal therapeutic targets, although the complexity of their signaling makes drug design challenging. In this review, we discuss the role of NRs in erythropoiesis, in both homeostatic and stress conditions. This knowledge is important in view of modulating red blood cells production in disease conditions, such as anemias, and for the expansion of erythroid cells in culture for research purposes and for reaching the long-term goal of cultured blood for transfusion.

Citing Articles

The Role of Nutrition on Thyroid Function.

Shulhai A, Rotondo R, Petraroli M, Patianna V, Predieri B, Iughetti L Nutrients. 2024; 16(15).

PMID: 39125376 PMC: 11314468. DOI: 10.3390/nu16152496.


Global Transcriptomic and Characteristics Comparisons between Mouse Fetal Liver and Bone Marrow Definitive Erythropoiesis.

Gao C, Zhang H, Wang Y, Wang S, Guo X, Han Y Cells. 2024; 13(13.

PMID: 38995000 PMC: 11240549. DOI: 10.3390/cells13131149.


Current investigations for liver fibrosis treatment: between repurposing the FDA-approved drugs and the other emerging approaches.

Mohammed O, Attia H, Mohamed B, Elbaset M, Fayed H J Pharm Pharm Sci. 2023; 26:11808.

PMID: 38022905 PMC: 10662312. DOI: 10.3389/jpps.2023.11808.


Relationship between Iron Deficiency and Thyroid Function: A Systematic Review and Meta-Analysis.

Garofalo V, Condorelli R, Cannarella R, Aversa A, Calogero A, La Vignera S Nutrients. 2023; 15(22).

PMID: 38004184 PMC: 10675576. DOI: 10.3390/nu15224790.


Are sex differences in blood cell count and hemoglobin moderated by the 2D:4D ratio? A cross-sectional study in a Ghanaian population.

Banyeh M, Kangkpi T, Bani S, Zogli K, Tanko M, Atuahene P Health Sci Rep. 2023; 6(9):e1547.

PMID: 37670848 PMC: 10476464. DOI: 10.1002/hsr2.1547.


References
1.
Han C, Park S, Cheng S . NCOR1 modulates erythroid disorders caused by mutations of thyroid hormone receptor α1. Sci Rep. 2017; 7(1):18080. PMC: 5741760. DOI: 10.1038/s41598-017-18409-4. View

2.
Kruse S, Suino-Powell K, Zhou X, Kretschman J, Reynolds R, Vonrhein C . Identification of COUP-TFII orphan nuclear receptor as a retinoic acid-activated receptor. PLoS Biol. 2008; 6(9):e227. PMC: 2535662. DOI: 10.1371/journal.pbio.0060227. View

3.
Pascual A, Aranda A . Thyroid hormone receptors, cell growth and differentiation. Biochim Biophys Acta. 2012; 1830(7):3908-16. DOI: 10.1016/j.bbagen.2012.03.012. View

4.
Yoon K, Chen C, Orr A, Barreto P, Tamamis P, Safe S . Activation of COUP-TFI by a Novel Diindolylmethane Derivative. Cells. 2019; 8(3). PMC: 6468570. DOI: 10.3390/cells8030220. View

5.
Sankaran V, Menne T, Xu J, Akie T, Lettre G, Van Handel B . Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A. Science. 2008; 322(5909):1839-42. DOI: 10.1126/science.1165409. View